Trademark: 76359549
Status Date
Friday, September 21, 2012
Registration Number
2988451
Registration Date
Tuesday, August 30, 2005
Filing Date
Wednesday, January 16, 2002
Published for Opposition
Tuesday, June 7, 2005
Cancellation Date
Friday, September 21, 2012
1 Chemicals, biochemical, biotechnological and bacteriological products namely, polypeptides for in vivo and invitro genetic engineering, natural and engineered meganuclease and endonuclease, nucleic acid vectors encoding the natural or engineered meganuclease or endonuclease or nucleic acid vectors comprising their recognition and cleavage site; ready to use genomic recombination system comprised primarily of reagents for scientific use; cells engineered by meganuclease recombination systems for scientific research use and therapeutic use, chemical agents, biochemical, biotechnologic and bacteriological products for use in scientific research laboratories and control laboratories namely cells, reagents, and culture media; diagnostic reagents for scientific use; proteins for use in scientific research; biotechnological preparations used as molecular scissors in scientific research
5 Pharmaceutical, veterinary, and health care products, namely polypeptides for in vivo and in vitro genetic engineering for use in the treatment of cystic fibrosis, Duchesne muscular dystrophy, and Alpha 1 antitrypsin disease; natural and engineered meganucleases and endonucleases, nucleic acid vectors encoding the natural or engineered meganuclease or endonuclease or nucleic acid vectors comprising their recognition and cleavage site, all for use in the treatment of sickle cell anemia, X-SciD, and Rs-SciD; ready to use genomic recombination system comprised primarily of meganuclease recombination system for use in the treatment of muscular dystrophy; cells engineered by meganuclease recombination system for use in the treatment of genetic and viral disease, microorganism cultures and bacteriological preparations for use in the treatment of genetic and viral disease; chemotherapeutic preparations for use in the treatment of cancer; diagnostic preparations for clinical medical use
42 Scientific and industrial research; research for others in genetic, medical, pharmaceutical, and veterinary fields; research for others in chemistry, biology, biochemistry, molecular biology, bacteriology; scientific analysis services, research and development for others of techniques of biochemical analysis, biological analysis, molecular biology techniques, research and development of new molecules intended for industry, scientific laboratory services; conducting scientific research studies relating to engineering, natural, and engineered meganuclease and endonuclease, and meganuclease recombination systems; licensing of patents and of intellectual property; computer programming for others; and development for others of software programs and multimedia products
Sep 21, 2012
Cancelled Sec. 8 (6-Yr)
Aug 30, 2005
Exparte Appeal Terminated
Aug 30, 2005
Registered-Principal Register
Jun 7, 2005
Published For Opposition
May 18, 2005
Notice Of Publication
Feb 18, 2005
Law Office Publication Review Completed
Feb 15, 2005
Assigned To Lie
Jan 31, 2005
Assigned To Lie
Jan 26, 2005
Approved For Pub - Principal Register
Aug 13, 2004
Jurisdiction Restored To Examining Attorney
Jul 28, 2004
Paper Received
Aug 10, 2004
Paper Received
Aug 10, 2004
Ex Parte Appeal-Instituted
Aug 4, 2004
Exparte Appeal Received At Ttab
Jan 26, 2004
Final Refusal Mailed
Oct 24, 2003
Correspondence Received In Law Office
Nov 20, 2003
Case File In Ticrs
Oct 24, 2003
Paper Received
Jul 23, 2003
Letter Of Suspension Mailed
Apr 7, 2003
Correspondence Received In Law Office
Apr 7, 2003
Paper Received
Mar 14, 2003
Correspondence Received In Law Office
Mar 14, 2003
Paper Received
Mar 7, 2003
Letter Of Suspension Mailed
Dec 11, 2002
Correspondence Received In Law Office
Dec 11, 2002
Paper Received
Mar 26, 2002
Correspondence Received In Law Office
Jun 19, 2002
Non-Final Action Mailed
Mar 26, 2002
Paper Received
Apr 3, 2002
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
